Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-09-23

Clinical Trial Update: Non-interventional Open Label Study to Investigate the Effect of Quetiapine XR on Patient Satisfaction and Quality of Life in Patients With Schizophrenia

View source ↗

Summary

A completed non-interventional, open-label study evaluating the effect of Quetiapine XR on patient satisfaction and quality of life in people with schizophrenia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Quetiapine XR (quetiapine)

Snippet

Sponsor: AstraZeneca | Conditions: Quality of Life in Schizophrenia | Status: COMPLETED